What Nuritas supplies
Nuritas is a Dublin company that discovers and sells bioactive peptides, short chains of amino acids found in or released from food proteins. Its homepage describes ready-to-use, clinically proven peptide ingredients for oral and topical formulations and a service for custom peptide discovery. The business serves supplement and wellness brands, rather than bulk protein buyers.
Three ingredients are listed: PeptiStrong for muscle health, PeptiSleep and PeptiYouth. PeptiStrong is the best documented on the website. It is described as a network of clinically studied cell-signalling peptides from fava beans. The company says it signals cells to build and maintain muscle strength, recover and use energy, and positions it beside creatine and protein, not as a replacement.
The plant source places Nuritas next to producers of fava bean protein, although the product is not the protein itself. The company explains that through its process the benefits are released in a way that the bean alone does not provide. For formulators, the distinction matters because dosing, taste and labelling follow peptide rules rather than protein rules.
Technology and evidence
The core asset is Magnifier, a proprietary AI platform built to identify and validate smart peptides from nature. The homepage reports a library of over eight million peptides with known functions, 56 patents issued and an 80% success rate in predicting efficacy from in vitro results to clinical outcomes. These figures describe the platform, not a given lot.
For PeptiStrong the website names mechanisms: signalling through mTOR and phospho-S6 pathways to raise muscle synthesis, reduced breakdown markers Atrogin and MuRF1, and greater mitochondrial mass. It cites clinical results, including a 17% strength increase against placebo, faster strength recovery and less fatigue, with references to a 2023 Journal of Nutrition paper.
Buyers should read these results as supplier summaries, not independent reviews. Dose, duration and population decide whether an effect carries over to a product, and a Vicia faba peptide study in young men cannot be generalised to older adults without more data on that group. The company offers a brochure and a sample on request for evaluation.
Applications and positioning
PeptiStrong is aimed at sports and muscle health products, and the news list shows a nutrition brand launching a creatine product powered by it. Nuritas also lists PeptiSleep, backed by a peer-reviewed sleep study in Sleep Medicine, and PeptiYouth, and a peptide guide on the site explains the concept in plain terms.
The company presents partnerships as a second route. Brands can ask for a custom peptide discovery programme tuned to a specific health outcome. Such projects take longer than purchasing a listed ingredient, and they raise questions on exclusivity, ownership of discovered sequences and access to clinical data, which should be settled in a contract before any work begins.
The site carries the disclaimer that its statements have not been evaluated by the Food and Drug Administration and that the product is not intended to diagnose, treat, cure or prevent disease. That is typical for supplement ingredients and signals that benefit claims depend on the market and wording, so each claim needs legal review.
What a buyer would check
Regulatory status is first. Peptide ingredients are treated as dietary ingredients, novel foods or something else depending on the region, and the European Union restricts health claims to authorised wording. Ask Nuritas which markets each ingredient can be sold in, which notifications or opinions support it, and what label descriptors it recommends.
Technical specification follows. Request a certificate of analysis showing peptide content, molecular weight distribution, moisture, solubility, taste profile and heavy metals, plus allergen information. A fava-derived ingredient raises legume sensitivity questions that should be covered in the declaration. Compare cost per effective dose with protein-based alternatives, since peptides act at low inclusion levels.
Finally, evaluate evidence quality. Buyers should request full clinical reports and check whether trials had supplier involvement and whether the dose used matches the planned product dose. Confirm supply volumes, lead times and a second source, and agree how new data, such as further sleep or youth studies, will be shared with customers.